Alvotech (ALVO) Earnings Date & Reports

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALVO is expected to report earnings to fall 118.86% to 2 cents per share on May 07

Q1'25

Est.

$0.03

Q4'24

Missed

by $0.15

Q3'24

Beat

by $0.03

Q2'24

Missed

by $0.59

Q1'24

Missed

by $0.81

The last earnings report on March 26 showed earnings per share of -14 cents, missing the estimate of 0 cents. With 72.66K shares outstanding, the current market capitalization sits at 3.48B.

View a ticker or compare two or three

Compare

ALVO